Science Current Events | Science News | Brightsurf.com
 

Cell skeleton may hold key to overcoming drug resistance in cancer

October 04, 2007
Researchers have uncovered a new way in which a cell protein protects cancer cells from a wide range of chemotherapeutic drugs, identifying a possible target for improving treatment outcomes for patients.

A team of scientists at Children's Cancer Institute Australia for Medical Research (CCIA), led by Associate Professor Maria Kavallaris, discovered that the bIII-tubulin component of the cell's cytoskeleton could play an important role in resistance to a wide range of drugs used to treat lung, ovarian and breast cancers.

Advanced non-small cell lung carcinomas (NSCLC) account for more than 80 per cent of lung cancer cases. More than one million people are diagnosed with lung cancer every year, the most common cancer in the world and the leading cause of cancer deaths. Chemotherapy remains the most effective treatment option, involving a diverse range of drugs, often used in combination. However, the emergence of drug-resistant tumours in NSCLC means chemotherapy no longer holds the promise of a good outcome for many patients.

Increased expression of bIII-tubulin has been linked to drug resistance in NSCLC, ovarian and breast cancers. In the latest Cancer Research publication, Associate Professor Kavallaris and her team showed that blocking the expression of the bIII-tubulin gene in NSCLC cells led to an increase in their sensitivity to a range of chemotherapeutic drugs.

"Our results strongly suggest that the bIII-tubulin component is responsible for protecting NSCLC cells from the action of key chemotherapeutic drugs," said Associate Professor Kavallaris.

"This is the first scientific evidence for the broader implications of abnormal expression of this protein.

"We now have new insight into a mechanism of drug resistance in NSCLC which has not previously been reported. This has important implications for improving the targeting and treatment of a number of cancers which are resistant to current chemotherapeutic drugs," said Associate Professor Kavallaris.

Research Australia


Related Chemotherapeutic Drug Current Events and Chemotherapeutic Drug News Articles


CNIO associates rare gene variants with side effects from chemotherapy with paclitaxel
Paclitaxel is a chemotherapeutic drug that has been shown to be highly effective when treating solid tumours, such as breast, ovarian and lung tumours.

Major discovery on the mechanism of drug resistance in leukemia and other cancers
A mechanism that enables the development of resistance to Acute Myeloid Leukemia (AML) anticancer drugs, thereby leading to relapse, has been identified by Kathy Borden of the University of Montreal's Institute for Research in Immunology and Cancer (IRIC) and her collaborators.

Genetic aberration paves the way for new treatment of cancer disease
Researchers from Faculty of Health and Medical Sciences, University of Copenhagen, have characterized a genetic aberration on a group of colorectal cancer patients.

Nanotech system, cellular heating may improve treatment of ovarian cancer
The combination of heat, chemotherapeutic drugs and an innovative delivery system based on nanotechnology may significantly improve the treatment of ovarian cancer while reducing side effects from toxic drugs, researchers at Oregon State University report in a new study.

Celery, artichokes contain flavonoids that kill human pancreatic cancer cells
Celery, artichokes, and herbs, especially Mexican oregano, all contain apigenin and luteolin, flavonoids that kill human pancreatic cancer cells in the lab by inhibiting an important enzyme, according to two new University of Illinois studies.

More Effective Immunotherapy for Melanoma Hinges on Blocking Suppressive Factors, Moffitt Cancer Center Researchers Say
Researchers at the Moffitt Cancer Center have found that delayed tumor growth and enhanced survival of mice bearing melanoma were possible by blocking the reconstitution of myeloid-derived suppressor cells and Tregs (suppressors of anti-tumor activity) after total body irradiation had eliminated them.

CWRU School of Medicine researchers discover gene that permanently stops cancer cell proliferation
Researchers at Case Western Reserve University School of Medicine have discovered a mutant form of the gene, Chk1, that when expressed in cancer cells, permanently stopped their proliferation and caused cell death without the addition of any chemotherapeutic drugs.

Regulation by proteins outside cancer cells points to potential new drug target
Protein interactions outside breast cancer cells can send signals to the cancer cells to permanently stop proliferating, a new study showed in the School of Medicine at The University of Texas Health Science Center San Antonio.

Nanoparticles engineered at Notre Dame promise to improve blood cancer treatment
Researchers from the University of Notre Dame have engineered nanoparticles that show great promise for the treatment of multiple myeloma (MM), an incurable cancer of the plasma cells in bone marrow.

Experimental agent may help older people with chronic leukemia
The experimental drug ibrutinib (PCI-32765) shows great promise for the treatment of elderly patients with chronic lymphocytic leukemia (CLL), according to interim findings from a clinical trial.
More Chemotherapeutic Drug Current Events and Chemotherapeutic Drug News Articles

2015 Oncology Nursing Drug Handbook

2015 Oncology Nursing Drug Handbook
by Gail M. Wilkes (Author), Margaret Barton-Burke (Author)


Written especially for nurses caring for patients with cancer, the 2015 Oncology Nursing Drug Handbook uniquely expresses drug therapy in terms of the nursing process: nursing diagnoses, etiologies of toxicities, and key points for nursing assessment, intervention, and evaluation. Updated annually, this essential reference provides valuable information on effective symptom management, patient education, and chemotherapy administration. Completely revised and updated, the 2015 Oncology Nursing Drug Handbook includes a simplified chapter on molecular and biological targeted therapy that incorporates new information about immunotherapy, new indications, and the most important and common side effects. New drug entries include: afatinib, belinostat, ceritinib, ibrutinib, idelalisib,...

Burger's Medicinal Chemistry and Drug Discovery, Chemotherapeutic Agents (Burger's Medicinal Chemistry & Drug Discovery) (Volume 5)

Burger's Medicinal Chemistry and Drug Discovery, Chemotherapeutic Agents (Burger's Medicinal Chemistry & Drug Discovery) (Volume 5)
by Donald J. Abraham (Editor)


This is Volume 5: Chemotherapeutic Agents, of Burger's Medicinal Chemistry and Drug Discovery, 6th Edition. This new volume contains critical new chapters on Molecular Biology of Cancer, Synthetic Anti-angiogenic Agents and Selective Toxicities.

To purchase the entire 6 volume set, please refer to ISBN 0-471-37032-0.

For a complete list of articles and contributors as well as FREE sample chapters from this new 6th Edition please visit: www.mrw.interscience.wiley.com/bmcdd

Litt's Drug Eruption and Reaction Manual, 21st Edition

Litt's Drug Eruption and Reaction Manual, 21st Edition
by Jerome Z. Litt (Author)


Internationally relied upon by medical practitioners for its unparalleled focus on adverse effects and cutaneous reactions, this succinct clinical reference is the essential drug-safety tool for patient care. The book provides complete coverage of the reaction profiles of numerous prescription and over-the-counter drugs and supplements and includes convenient lists of classes of drugs known to cause reactions. This 21st edition has been comprehensively revised and updated, featuring an enlarged section of tables for class reactions and new entries for recently licensed drugs.

Litt's D.E.R.M. Drug Eruptions and Reactions Manual, 20th Edition (Drug Eruption Reference Manual)

Litt's D.E.R.M. Drug Eruptions and Reactions Manual, 20th Edition (Drug Eruption Reference Manual)
by Jerome Z. Litt (Author)


Relied upon by dermatologists and medical practitioners internationally for its unparalleled practical focus on adverse effects and cutaneous reactions, this text is the essential quick-reference tool for patient care and drug safety. The reaction data for this new 20th edition is compiled from the companion website, which is updated continuously, and includes prescription and over-the-counter drugs as well as biologics, supplements, and other medical products—with tens of thousands of adverse drug reactions, eruptions, and reaction patterns. The text notes the number of peer-reviewed references for reaction listings, the reported incidence of a reaction, and clinically important and potentially serious interactions between drugs.

2014 Oncology Nursing Drug Handbook

2014 Oncology Nursing Drug Handbook
by Gail M. Wilkes (Author), Margaret Barton-Burke (Author)


Written especially for nurses caring for patients with cancer, the 2014 Oncology Nursing Drug Handbook uniquely expresses drug therapy in terms of the nursing process: nursing diagnoses, etiologies of toxicities, and key points for nursing assessment, intervention, and evaluation. Updated annually, this essential reference provides valuable information on effective symptom management, patient education, and chemotherapy administration. Completely revised and updated, the 2014 Oncology Nursing Drug Handbook includes: * New chapter on Chemobiotherapy for Noncancer Diseases * Specific drugs described in terms of their mechanism of action, metabolism, drug interactions, laboratory effects/interference, and special considerations * The most important and common drug side effects * Greater...

MedNotes: Pocket Drug Guide (Davis's Notes)

MedNotes: Pocket Drug Guide (Davis's Notes)
by Judith Hopfer Deglin PharmD (Author), April Hazard Vallerand PhD RN FAAN (Author)


A DAVIS’S NOTES BOOK! Instant access to all of the essential medical information you need! Drawing on the content of its best-selling parent reference, Davis’s Drug Guide for Nurses, it provides essential information on over 170 top medications commonly prescribed in acute and ambulatory care, including high-alert and emergency drugs! Quickly find content on patient safety—with vital information on pediatric and geriatric considerations—as well as precautions for all vulnerable populations.

Psychopharmacology: Drugs, the Brain and Behavior

Psychopharmacology: Drugs, the Brain and Behavior
by Jerrold S. Meyer (Author), Linda F. Quenzer (Author)


Recent advances in molecular pharmacology and brain imaging have revolutionized our understanding of how psychoactive drugs work. Now, from the authors of Principles of Neuropsychopharmacology, comes a new undergraduate textbook integrating these developments. The first section of the book provides extensive foundation materials, including the basic principles of pharmacology, neurophysiology and neuroanatomy, synaptic transmission, and methods in psychopharmacology. The second section describes key features of major neurotransmitter systems, including the catecholamines, serotonin, acetylcholine, glutamate and GABA. The third and fourth sections discuss theories and mechanisms of drug addiction and psychopathology. All major substances of abuse as well as drugs used to treat mental...

Physicians' Cancer Chemotherapy Drug Manual 2014 (Jones and Bartlett Series in Oncology(Physician's Cancer Chemotherapy Drug Manual))

Physicians' Cancer Chemotherapy Drug Manual 2014 (Jones and Bartlett Series in Oncology(Physician's Cancer Chemotherapy Drug Manual))
by Edward Chu (Author), Vincent T. DeVita Jr. (Author)


Completely revised and updated for 2014, the Physicians’ Cancer Chemotherapy Drug Manual 2014 is an up-to-date guide to the latest information on standard therapy and recent advances in the field. Written by world-class experts in clinical cancer therapeutics, this essential reference provides a complete, easy-to-use catalog of over 100 drugs and commonly used drug regimens—both on- and off-label—for the treatment of all the major cancers. Special features: • Revised to reflect rapid advances in the field • A specific chapter focused on profiling antiemetic drug and antiemetic treatment regimens. • Diagrams of drug structures and pathways for many of the agents. • Offers a comprehensive discussion of clinical pharmacology, special considerations, indications, and dosages....

Katzung & Trevor's Pharmacology Examination and Board Review,10th Edition (Katzung & Trevor's Pharmacology Examination & Board Review)

Katzung & Trevor's Pharmacology Examination and Board Review,10th Edition (Katzung & Trevor's Pharmacology Examination & Board Review)
by Anthony Trevor (Author), Bertram Katzung (Author), Susan Masters (Author), Marieke Knuidering-Hall (Author)


MORE THAN 1000 Q&As PREPARE YOU FOR MEDICAL PHARMACOLOGY COURSE EXAMS AND BOARD EXAMINATIONS From the authors of pharmacology's #1 textbook, Katzung & Trevor's Basic & Clinical Pharmacology, Twelfth Edition, this review delivers a clear, concise review of fundamental concepts backed by more than 1,000 review questions and answers. The chapter-based approach facilitates use with course notes or larger texts. Outstanding learning aids include: Short discussion of the major concepts that underlie basic principles or specific drug groups Explanatory figures and tables Review questions followed by answers and explanations Drug trees in drug-oriented chapters that visually organize drug groups A list of high-yield terms and definitions you need to know Skill Keeper Questions that prompt you to...

Drug-induced and Iatrogenic Respiratory Disease (Hodder Arnold Publication)

Drug-induced and Iatrogenic Respiratory Disease (Hodder Arnold Publication)
by Phillipe Camus (Author), Edward C Rosenow III (Author)


At the present time, 430 drugs are known to cause respiratory injury. This represents an increase of almost 200 in the last ten years, and the number is still increasing. This comprehensive, definitive reference work, with an outstanding range of international expert contributors and two of the world's leading editors, provides an essential reference for the practising respiratory physician.

Key features:


The text builds upon basics with a review of basic sciences.
The book covers imaging, varied drug-induced interstitial lung disease including pulmonary edema and diffuse alveolar hemorrhage, acute respiratory failure, pleural involvement and upper to lower airway disease
A wide range of diseases are detailed from chemotherapy and radiation to...

© 2015 BrightSurf.com